On January 18, Zhang Yi, Vice President of CPPCC of Beibei District of Chongqing and Director of Chongqing Beibei Food and Drug Administration, visits and investigates the Hemony Pharmaceutical along with his delegation.
The investigation team visits the R&D Center and Product Showroom of the Hemony Pharmaceutical, has an understanding of the medicine production process and quality control system, and praises the professional R&D and management ability of the Hemony Pharmaceutical.
On the symposium, Xia Jun, Director of Administration Department, briefs the Company’s development to the investigation team. Li Zhiliang, Deputy General Manager, reports on the acquisition of imported medicine makers, conformance assessment of generic drugs and development of innovative drugs. On top of that, he also expresses a sincere gratitude to the guidance and assistance by the Chongqing Beibei Food and Drug Administration to the Hemony Pharmaceutical for a long time.
Zhang Yi also mentions that Chongqing Beibei Food and Drug Administration will continue strengthening the communication with the Hemony Pharmaceutical as a supervision department, perform its duty well and offer a good service to assist the enterprise to realize a sound and sustainable development. Hemony Pharmaceutical must confirm its confidence in reforming and innovating, strengthening awareness of quality and safety, and improving the comprehensive management level continuously so as to provide patients more effective drugs in larger quantity.
Li Zhiliang, Deputy General Manager of the Hemony Pharmaceutical, Li Jun, Director of Administration Department as well as the leaders of QA Department and other relevant department accompany this investigation.